JAGSONPAL PHARMACEUTICALS
|
The Current P/S Ratio of JAGSONPAL PHARMACEUTICALS is 4.80.
| Share Price | ₹209.6 | Jun 17,2026 |
| Market Cap | ₹1,379.2 Cr | |
| Sales-TTM | ₹287.2 Cr | TTM-Standalone Results |
| Price/Sales | 4.80x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of JAGSONPAL PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,379.2 Cr] as on Jun 17,2026
(/) Sales [ ₹287.2 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 4.80x ]
Thus, for JAGSONPAL PHARMACEUTICALS , the investors are currently willing to pay '4.80 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of JAGSONPAL PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of JAGSONPAL PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of JAGSONPAL PHARMACEUTICALS
PS Ratio Performance Analysis for JAGSONPAL PHARMACEUTICALS
- JAGSONPAL PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.40x.
- JAGSONPAL PHARMACEUTICALS 's operated at median p/e ratio of 3.55x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, JAGSONPAL PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 5.34x.
- JAGSONPAL PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 1.11x.
How does JAGSONPAL PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| JAGSONPAL PHARMACEUTICALS | 287.2 | 4.80 | 1,379.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.47 | 436,667.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 16.74 | 176,805.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 10.77 | 150,554.0 |
| CIPLA LTD | 28,162.6 | 3.87 | 109,120.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.14 | 105,920.0 |
| MANKIND PHARMA LTD | 14,277.6 | 6.84 | 97,611.6 |
| LUPIN LTD | 27,958.0 | 3.71 | 103,645.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 3.93 | 106,812.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.43 | 81,824.5 |
| LAURUS LABS LTD | 6,812.9 | 10.86 | 73,957.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs JAGSONPAL PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.43x |
| Max industry PS | 16.74x |
| Median industry PS | 4.80x |
| Average industry PS | 6.78x |
You may also like the below Video Courses